VYGR vs XYL · rev $5.8M vs P/E 27, rev $4.46B
Voyager Therapeutics Inc (VYGR) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
VYGR currently screens at market cap $225.4M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the VYGR and XYL stock pages for the full models.
Not investment advice.